1dig Citations

Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase/cyclohydrolase.

Biochemistry 39 6325-35 (2000)
Related entries: 1dia, 1dib

Cited: 35 times
EuropePMC logo PMID: 10828945

Abstract

Enzymes involved in tetrahydrofolate metabolism are of particular pharmaceutical interest, as their function is crucial for amino acid and DNA biosynthesis. The crystal structure of the human cytosolic methylenetetrahydrofolate dehydrogenase/cyclohydrolase (DC301) domain of a trifunctional enzyme has been determined previously with a bound NADP cofactor. While the substrate binding site was identified to be localized in a deep and rather hydrophobic cleft at the interface between two protein domains, the unambiguous assignment of catalytic residues was not possible. We succeeded in determining the crystal structures of three ternary DC301/NADP/inhibitor complexes. Investigation of these structures followed by site-directed mutagenesis studies allowed identification of the amino acids involved in catalysis by both enzyme activities. The inhibitors bind close to Lys56 and Tyr52, residues of a strictly conserved motif for active sites in dehydrogenases. While Lys56 is in a good position for chemical interaction with the substrate analogue, Tyr52 was found stacking against the inhibitors' aromatic rings and hence seems to be more important for proper positioning of the ligand than for catalysis. Also, Ser49 and/or Cys147 were found to possibly act as an activator for water in the cyclohydrolase step. These and the other residues (Gln100 and Asp125), with which contacts are made, are strictly conserved in THF dehydrogenases. On the basis of structural and mutagenesis data, we propose a reaction mechanism for both activities, the dehydrogenase and the cyclohydrolase.

Reviews - 1dig mentioned but not cited (1)

  1. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight. Cuthbertson CR, Arabzada Z, Bankhead A, Kyani A, Neamati N. ACS Pharmacol Transl Sci 4 624-646 (2021)

Articles - 1dig mentioned but not cited (3)

  1. Sequence and structure continuity of evolutionary importance improves protein functional site discovery and annotation. Wilkins AD, Lua R, Erdin S, Ward RM, Lichtarge O. Protein Sci 19 1296-1311 (2010)
  2. Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity. Eadsforth TC, Pinto A, Luciani R, Tamborini L, Cullia G, De Micheli C, Marinelli L, Cosconati S, Novellino E, Lo Presti L, Cordeiro da Silva A, Conti P, Hunter WN, Costi MP. J Med Chem 58 7938-7948 (2015)
  3. An assessment of three human methylenetetrahydrofolate dehydrogenase/cyclohydrolase-ligand complexes following further refinement. Bueno R, Dawson A, Hunter WN. Acta Crystallogr F Struct Biol Commun 75 148-152 (2019)


Reviews citing this publication (5)

  1. Acetogenesis and the Wood-Ljungdahl pathway of CO(2) fixation. Ragsdale SW, Pierce E. Biochim Biophys Acta 1784 1873-1898 (2008)
  2. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer. Dekhne AS, Hou Z, Gangjee A, Matherly LH. Mol Cancer Ther 19 2245-2255 (2020)
  3. Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment. Burda P, Kuster A, Hjalmarson O, Suormala T, Bürer C, Lutz S, Roussey G, Christa L, Asin-Cayuela J, Kollberg G, Andersson BA, Watkins D, Rosenblatt DS, Fowler B, Holme E, Froese DS, Baumgartner MR. J Inherit Metab Dis 38 863-872 (2015)
  4. Folates in Trypanosoma brucei: Achievements and Opportunities. Cullia G, Tamborini L, Conti P, De Micheli C, Pinto A. ChemMedChem 13 2150-2158 (2018)
  5. Regulatory mechanisms of one-carbon metabolism enzymes. Petrova B, Maynard AG, Wang P, Kanarek N. J Biol Chem 299 105457 (2023)

Articles citing this publication (26)

  1. Serine Catabolism Feeds NADH when Respiration Is Impaired. Yang L, Garcia Canaveras JC, Chen Z, Wang L, Liang L, Jang C, Mayr JA, Zhang Z, Ghergurovich JM, Zhan L, Joshi S, Hu Z, McReynolds MR, Su X, White E, Morscher RJ, Rabinowitz JD. Cell Metab 31 809-821.e6 (2020)
  2. Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls. Prasannan P, Pike S, Peng K, Shane B, Appling DR. J Biol Chem 278 43178-43187 (2003)
  3. Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development. Tedeschi PM, Vazquez A, Kerrigan JE, Bertino JR. Mol Cancer Res 13 1361-1366 (2015)
  4. Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major. Murta SM, Vickers TJ, Scott DA, Beverley SM. Mol Microbiol 71 1386-1401 (2009)
  5. The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD. Fu C, Sikandar A, Donner J, Zaburannyi N, Herrmann J, Reck M, Wagner-Döbler I, Koehnke J, Müller R. Nat Commun 8 1529 (2017)
  6. Disruption of the mthfd1 gene reveals a monofunctional 10-formyltetrahydrofolate synthetase in mammalian mitochondria. Christensen KE, Patel H, Kuzmanov U, Mejia NR, MacKenzie RE. J Biol Chem 280 7597-7602 (2005)
  7. Human mitochondrial C1-tetrahydrofolate synthase: submitochondrial localization of the full-length enzyme and characterization of a short isoform. Prasannan P, Appling DR. Arch Biochem Biophys 481 86-93 (2009)
  8. Magnesium and phosphate ions enable NAD binding to methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase. Christensen KE, Mirza IA, Berghuis AM, Mackenzie RE. J Biol Chem 280 34316-34323 (2005)
  9. Protein interaction and functional data indicate MTHFD2 involvement in RNA processing and translation. Koufaris C, Nilsson R. Cancer Metab 6 12 (2018)
  10. Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2. Asai A, Koseki J, Konno M, Nishimura T, Gotoh N, Satoh T, Doki Y, Mori M, Ishii H. Heliyon 4 e01021 (2018)
  11. Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold. Kawai J, Ota M, Ohki H, Toki T, Suzuki M, Shimada T, Matsui S, Inoue H, Sugihara C, Matsuhashi N, Matsui Y, Takaishi S, Nakayama K. ACS Med Chem Lett 10 893-898 (2019)
  12. Acinetobacter baumannii FolD ligand complexes --potent inhibitors of folate metabolism and a re-evaluation of the structure of LY374571. Eadsforth TC, Maluf FV, Hunter WN. FEBS J 279 4350-4360 (2012)
  13. Structure of methylene-tetrahydromethanopterin dehydrogenase from methylobacterium extorquens AM1. Ermler U, Hagemeier CH, Roth A, Demmer U, Grabarse W, Warkentin E, Vorholt JA. Structure 10 1127-1137 (2002)
  14. Functional role for the conformationally mobile phenylalanine 223 in the reaction of methylenetetrahydrofolate reductase from Escherichia coli. Lee MN, Takawira D, Nikolova AP, Ballou DP, Furtado VC, Phung NL, Still BR, Thorstad MK, Tanner JJ, Trimmer EE. Biochemistry 48 7673-7685 (2009)
  15. Assessment of Pseudomonas aeruginosa N5,N10-methylenetetrahydrofolate dehydrogenase-cyclohydrolase as a potential antibacterial drug target. Eadsforth TC, Gardiner M, Maluf FV, McElroy S, James D, Frearson J, Gray D, Hunter WN. PLoS One 7 e35973 (2012)
  16. The crystal structure of Leishmania major N(5),N(10)-methylenetetrahydrofolate dehydrogenase/cyclohydrolase and assessment of a potential drug target. Eadsforth TC, Cameron S, Hunter WN. Mol Biochem Parasitol 181 178-185 (2012)
  17. The enzymes of the 10-formyl-tetrahydrofolate synthetic pathway are found exclusively in the cytosol of the trypanosomatid parasite Leishmania major. Vickers TJ, Murta SM, Mandell MA, Beverley SM. Mol Biochem Parasitol 166 142-152 (2009)
  18. Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2). Lee LC, Peng YH, Chang HH, Hsu T, Lu CT, Huang CH, Hsueh CC, Kung FC, Kuo CC, Jiaang WT, Wu SY. J Med Chem 64 11288-11301 (2021)
  19. NAD- and NADP-dependent mitochondrially targeted methylenetetrahydrofolate dehydrogenase-cyclohydrolases can rescue mthfd2 null fibroblasts. Patel H, Di Pietro E, Mejia N, MacKenzie RE. Arch Biochem Biophys 442 133-139 (2005)
  20. The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform-Selective Inhibitors. Scaletti ER, Gustafsson Westergren R, Andersson Y, Wiita E, Henriksson M, Homan EJ, Jemth AS, Helleday T, Stenmark P. ChemMedChem 17 e202200274 (2022)
  21. Letter Metabolism of methionine derived from deuterated serine infused in a human. Baggott JE. Am J Clin Nutr 74 701-703 (2001)
  22. Molecular structure of a 5,10-methylenetetrahydrofolate dehydrogenase from the silkworm Bombyx mori. Haque MR, Higashiura A, Nakagawa A, Hirowatari A, Furuya S, Yamamoto K. FEBS Open Bio 9 618-628 (2019)
  23. The catalytic mechanism of the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2). Zhao LN, Kaldis P. PLoS Comput Biol 18 e1010140 (2022)
  24. Physiological role of FolD (methylenetetrahydrofolate dehydrogenase), FchA (methenyltetrahydrofolate cyclohydrolase) and Fhs (formyltetrahydrofolate synthetase) from Clostridium perfringens in a heterologous model of Escherichia coli. Aluri S, Sah S, Miryala S, Varshney U. Microbiology (Reading) 162 145-155 (2016)
  25. 5-Formyltetrahydrofolate promotes conformational remodeling in a methylenetetrahydrofolate reductase active site and inhibits its activity. Yamada K, Mendoza J, Koutmos M. J Biol Chem 299 102855 (2023)
  26. Beating cancer one carbon at a time. Dionellis VS, Halazonetis TD. Nat Cancer 3 141-142 (2022)


Related citations provided by authors (1)